We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Hydroxychloroquine and Lopinavir/Ritonavir Treatment Arms for COVID-19 Discontinued

News   Jul 06, 2020 | Original story from the World Health Organization (WHO)

 
Hydroxychloroquine and Lopinavir/Ritonavir Treatment Arms for COVID-19 Discontinued

Credit: Miguel Á. Padriñán, Pexels

 
 
Advertisement
 

RELATED ARTICLES

Large Clinical Trial To Test Polyclonal Antibody Therapeutic for COVID-19

News

A trial evaluating a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has begun enrolling non-hospitalized people with mild or moderate cases of COVID-19.

READ MORE

New Approach to Gene Therapy Bypasses “Broken” Genes

News

Researchers have developed a new approach to gene editing using the CRISPR/Cas9 system. The method bypasses disease-causing mutations in a gene, enabling treatment of genetic diseases linked to a single gene, such as cystic fibrosis, certain types of sickle cell anemia, and other rare diseases.

READ MORE

Silica Sponges Stimulate the Immune System

News

In order to increase immunotherapy precision and limit undesirable side effects, a team has developed silica nanoparticles with a very precise opening mechanism that can transport a drug exactly to where it should act. These microscopic vehicles could possibly be used not just for cancer treatment, but also to deliver other drugs at the very heart of our immune system, thus paving the way for entirely new therapeutic or preventive strategies.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE